Suchergebnisse - "Wei, XiaWei"

PubPharm (480)

1

Cisplatin-induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP-1/CCL2 and LTB4/LTB4R pathways

enthalten in: Cell proliferation | 2024

von Nie, J. | Ai, J. | Hong, W. | +8

2

Strategies and techniques for preclinical therapeutic targeting of PI3Kin oncology : where do we stand in 2024?

enthalten in: Expert opinion on therapeutic targets | 2024

von Liu, Y. | Sun, Q. | Wei, X.

3

IONIZABLE LIPIDS AND COMPOSITIONS FOR NUCLEIC ACID DELIVERY

enthalten in: Europäisches Patentamt | 2024

von SONG XIANGRONG | WEI XIAWEI | WEI YUQUAN

4

1H-PYRROLO[2,3-C]PYRIDINE COMPOUNDS AND APPLICATION THEREOF

enthalten in: Europäisches Patentamt | 2024

von QIAN WENYUAN | WEI XIAWEI | YANG CHUNDAO | +3

5

Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses

enthalten in: Genes & diseases | 2024

von Chen, L. | Ren, W. | Lei, H. | +11

6

Targeting inflammation as cancer therapy

enthalten in: Journal of hematology & oncology | 2024

von Wang, M. | Chen, S. | He, X. | +2

7

Targeting inflammation as cancer therapy

enthalten in: Journal of hematology & oncology | 2024

von Wang, M. | Chen, S. | He, X. | +2

8

IONIZABLE LIPIDS AND COMPOSITIONS FOR NUCLEIC ACID DELIVERY

enthalten in: Europäisches Patentamt | 2024

von SONG XIANGRONG | WEI XIAWEI | WEI YUQUAN

9

SALT FORM OF PYRROLOTRIAZINE COMPOUND, CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | WEI XIAWEI | YOU XU | +3

10

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer

enthalten in: Genes & diseases | 2024

von Yu, M. | Wu, Y. | Li, Q. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]